Literature DB >> 22977507

Coding polymorphisms of bone morphogenetic protein 2 contribute to the development of childhood IgA nephropathy.

Jin-Soon Suh1, Won-Ho Hahn, Jong Seok Lee, Hae Jeong Park, Mi-Ja Kim, Sung Wook Kang, Joo-Ho Chung, Byoung-Soo Cho.   

Abstract

Bone morphogenetic proteins (BMPs) are multi-functional growth factors belonging to the transforming growth factor β (TGFB) superfamily and are important in both preservation of kidney function and resistance to injury. BMP2 is highly regulated in the kidney, and high affinity binding sites for BMP2 have been identified in kidney epithelial cells. BMP2 has been demonstrated to play various roles in the pathogenesis of renal diseases. However, the role of the BMP2 gene in glomerulonephritis has not been previously investigated. We aimed to evaluate the association of BMP2 gene polymorphisms with immunoglobulin A nephropathy (IgAN) in children. We evaluated 187 pediatric patients with biopsy-confimed IgAN and 262 healthy controls. Two coding single nucleotide polymorphisms (cSNPs) in the BMP2 gene [rs235768 (missense, Arg190Ser) and rs1049007 (synonymous, Ser87Ser)] were selected and genotyped by direct sequencing. Genotypes of rs1049007 were associated with childhood IgAN in the codominant model II (GG vs. AA) [p=0.02; OR (95% CI), 0.16 (0.04-0.70)] and in the recessive model [p=0.0023; OR (95% CI), 0.16 (0.04-0.69)]. We also found an association between rs235768 and IgAN in the codominant model II (TT vs. AA) [p=0.01; OR (95% CI), 0.08 (0.01-0.57)] and in the recessive model [p=0.0002; OR (95% CI), 0.07 (0.01-0.55)]. After Bonferroni correction, these associations of rs235768 and rs1049007 with IgAN risk remained significant. In the haplotype analysis, the TG haplotype [p=0.01; OR (95% CI), 6.76 (1.55-29.50) in the dominant model] and AA haplotype [p=0.01; OR (95% CI), 0.08 (0.01-0.59) in the recessive model] showed associations with IgAN. The BMP2 gene may contribute to susceptibility to IgAN in Korean children.

Entities:  

Year:  2011        PMID: 22977507      PMCID: PMC3440631          DOI: 10.3892/etm.2011.195

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  24 in total

1.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

Review 2.  Recent advances in BMP receptor signaling.

Authors:  Christina Sieber; Jessica Kopf; Christian Hiepen; Petra Knaus
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-07       Impact factor: 7.638

3.  Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells. Involvement of mitogen-activated protein kinase.

Authors:  G Ghosh Choudhury; Y S Kim; M Simon; J Wozney; S Harris; N Ghosh-Choudhury; H E Abboud; G Ghosh Choundhury; N Ghosh-Choundhury
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

4.  Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2.

Authors:  S Iwasaki; N Tsuruoka; A Hattori; M Sato; M Tsujimoto; M Kohno
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

Review 5.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

6.  BMP-7 protects mesangial cells from injury by polymeric IgA.

Authors:  Wai Long Chan; Joseph C K Leung; Loretta Y Y Chan; K Y Tam; Sydney C W Tang; Kar Neng Lai
Journal:  Kidney Int       Date:  2008-05-21       Impact factor: 10.612

7.  Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors.

Authors:  Yu-Lin Yang; Yi-Shiuan Liu; Lea-Yea Chuang; Jinn-Yuh Guh; Tao-Chen Lee; Tung-Nan Liao; Min-Yuan Hung; Tai-An Chiang
Journal:  Endocrinology       Date:  2008-10-01       Impact factor: 4.736

8.  CTGF inhibits BMP-7 signaling in diabetic nephropathy.

Authors:  Tri Q Nguyen; Peggy Roestenberg; Frans A van Nieuwenhoven; Niels Bovenschen; Zeke Li; Leon Xu; Noelynn Oliver; Jan Aten; Jaap A Joles; Cecilia Vial; Enrique Brandan; Karen M Lyons; Roel Goldschmeding
Journal:  J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 10.121

9.  The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer.

Authors:  Yong Park; Jee Won Kim; Dae Sik Kim; Eui Bae Kim; Se Jong Park; Jin Yong Park; Woo Suk Choi; Jong Gyu Song; Hee Yun Seo; Sang Cheul Oh; Byung Soo Kim; Jong Jae Park; Yeul Hong Kim; Jun Suk Kim
Journal:  Cancer Res Treat       Date:  2008-09-30       Impact factor: 4.679

Review 10.  BMP-7 as antagonist of organ fibrosis.

Authors:  Ralf Weiskirchen; Steffen K Meurer; Olav A Gressner; Jens Herrmann; Erawan Borkham-Kamphorst; Axel M Gressner
Journal:  Front Biosci (Landmark Ed)       Date:  2009-06-01
View more
  1 in total

1.  Genetic analyses of bone morphogenetic protein 2, 4 and 7 in congenital combined pituitary hormone deficiency.

Authors:  Jana Breitfeld; Susanne Martens; Jürgen Klammt; Marina Schlicke; Roland Pfäffle; Kerstin Krause; Kerstin Weidle; Dorit Schleinitz; Michael Stumvoll; Dagmar Führer; Peter Kovacs; Anke Tönjes
Journal:  BMC Endocr Disord       Date:  2013-12-01       Impact factor: 2.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.